Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
Open Access
- 12 May 2015
- journal article
- review article
- Published by American Diabetes Association in Diabetes Care
- Vol. 38 (6), 954-962
- https://doi.org/10.2337/dc15-0184
Abstract
On the basis of extensive studies in Joslin Clinic patients over 25 years, we propose a new model of diabetic nephropathy in type 1 diabetes. In this model, the predominant clinical feature of both early and late stages of diabetic nephropathy is progressive renal decline, not albuminuria. Progressive renal decline (estimated glomerular filtration rate loss >3.5 mL/min/year) is a unidirectional process that develops while patients have normal renal function. It progresses at an almost steady rate until end-stage renal disease is reached, albeit at widely differing rates among individuals. Progressive renal decline precedes the onset of microalbuminuria, and as it continues, it increases the risk of proteinuria. Therefore, study groups ascertained for microalbuminuria/proteinuria are enriched for patients with renal decline (decliners). We found prevalences of decliners in 10%, 32%, and 50% of patients with normoalbuminuria, microalbuminuria, and proteinuria, respectively. Whether the initial lesion of progressive renal decline is in the glomerulus, tubule, interstitium, or vasculature is unknown. Similarly unclear are the initiating mechanism and the driver of progression. No animal model mimics progressive renal decline, so etiological studies must be conducted in humans with diabetes. Prospective studies searching for biomarkers predictive of the onset and rate of progression of renal decline have already yielded positive findings that will help to develop not only accurate methods for early diagnosis but also new therapeutic approaches. Detecting in advance which patients will have rapid, moderate, or minimal rates of progression to end-stage renal disease will be the foundation for developing personalized methods of prevention and treatment of progressive renal decline in type 1 diabetes.Keywords
Funding Information
- NIH Clinical Center (DK-41526)
- Juvenile Diabetes Research Foundation International (1-2008-1018, 17-2013-8)
This publication has 47 references indexed in Scilit:
- Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosisJCI Insight, 2013
- The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal diseaseKidney International, 2012
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CThe New England Journal of Medicine, 2012
- Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 DiabetesJournal of the American Society of Nephrology, 2012
- Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 DiabetesJournal of the American Society of Nephrology, 2012
- Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 DiabetesThe New England Journal of Medicine, 2011
- Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and MicroalbuminuriaAn Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications CohortMicroalbuminuria Outcomes in Type 1 DiabetesJAMA Internal Medicine, 2011
- Risk for ESRD in Type 1 Diabetes Remains High Despite RenoprotectionJournal of the American Society of Nephrology, 2011
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 DiabetesThe New England Journal of Medicine, 2009
- Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 DiabeticsJournal of the American Society of Nephrology, 2008